Clearance Summary
OxSAT 100 received FDA 510(k) clearance under submission number K191574, sponsored by S.L.P. , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2020-04-09.
- Submission: K191574
- Applicant / Sponsor: S.L.P. , Ltd.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2700
- Decision date: 2020-04-09
Classification & Regulation
This clearance is catalogued under FDA product code DQA and 21 CFR 870.2700, within the Cardiovascular review panel as a Class II device.